The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
May 19th 2022, 8:12pm
A recent study found that patients who were referred for a right heart catheterization and had chronic obstructive pulmonary disease (COPD) more commonly had pulmonary hypertension, which is associated with high mortality.
May 15th 2022, 4:40pm
An abstract from the American Thoracic Society International Conference demonstrated that Black men have a greater risk of not receiving a proper diagnosis of emphysema, after race-based adjustments to spirometry found normal lung function.
May 12th 2022, 8:15pm
A prospective study found that a chronic obstructive pulmonary disease (COPD) and asthma physiology score (CAPS) of at least 21 points was a risk factor for in-hospital mortality in patients with acute exacerbations of COPD (AECOPD).
May 10th 2022, 4:00pm
The US Preventive Services Task Force (USPSTF) found after a reaffirmation process that there was no net benefit to screening asymptomatic adults for chronic obstructive pulmonary disease (COPD).
May 4th 2022, 6:44pm
A recent review found that home-based pulmonary rehab had comparable short-term benefits to outpatient pulmonary rehab, although the outcome quality was low.
May 2nd 2022, 6:40pm
A recent study found that patients with chronic obstructive pulmonary disease (COPD) are more likely to have coronary heart disease (CHD) compared with those without COPD.
April 27th 2022, 4:01pm
A randomized controlled trial found that patients with chronic obstructive pulmonary disease (COPD) needed less acute care when in peer support groups.
April 20th 2022, 7:25pm
A recent study found that early use of a pulmonary rehabilitation program improved several measures of pulmonary function in patients with comorbid asthma, chronic obstructive pulmonary disease (COPD), and obesity.
April 18th 2022, 6:40pm
A recent study found that primary care physicians (PCPs) and pulmonologists differ in their treatment methods and reference to guidelines when treating patients with chronic obstructive pulmonary disease (COPD).
April 15th 2022, 12:47pm
A recent study found that budesonide-based triple therapy was just as effective as fluticasone-based triple therapy, with less incidence of death and severe pneumonia.